(Q43732233)

English

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Finke PE

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Meurer LC

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Oates B

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Shah SK

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Loebach JL

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Mills SG

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

MacCoss M

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Castonguay L

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Malkowitz L

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Springer MS

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Gould SL

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

DeMartino JA

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

2469-2473

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Human chemokines: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Host factors and the pathogenesis of HIV-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 entry - an expanding portal for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemokine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900491-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(01)00491-7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43732233&oldid=2102901848"